SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-22-000049
Filing Date
2022-05-09
Accepted
2022-05-09 16:08:33
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20220331.htm   iXBRL 10-Q 1388632
2 EX-31.1 lgnd_33122exhibit311.htm EX-31.1 15163
3 EX-31.2 lgnd_33122exhibit312.htm EX-31.2 15396
4 EX-32.1 lgnd_33122exhibit321.htm EX-32.1 11341
10 lgnd-20220331_g1.jpg GRAPHIC 51754
  Complete submission text file 0000886163-22-000049.txt   7499626

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20220331.xsd EX-101.SCH 43924
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20220331_cal.xml EX-101.CAL 90342
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20220331_def.xml EX-101.DEF 243679
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20220331_lab.xml EX-101.LAB 641461
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20220331_pre.xml EX-101.PRE 404431
56 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20220331_htm.xml XML 1357273
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 22904957
SIC: 2834 Pharmaceutical Preparations